SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cistron Biotechnology(CIST)$.30
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Zvi Yammer who wrote (2344)6/24/1999 1:31:00 PM
From: Walter Morton  Read Replies (2) of 2742
 
You make a very good point about cleaning house before the sale. Further, I would not be surprised if our new leaders were placed in those positions as part of an ongoing negotiation (although that may not be true)as might have been the case with the sale to Techne. Some future buyer might be pulling the strings at CIST.

However, I find it quite surprising that you think that IL-1b patents would only be worth $18 million at best. If PMC is willing sign a $31 Million deal with CIST, then IL-1b is probably worth even more than that. Perhaps you were taking into account the time value of money, but what if the PMC deal is just the tip of the iceberg in terms of the potential of CIST's patents?

$31 million divide by 19 million shares = ?
and if the patents are worth more...... Add that to the book value per share and mmm mmm gooood.

I am shocked that some are willing to settle for $1.25 per share.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News